In the US, Milnacipran (milnacipran systemic) is a member of the drug class serotonin-norepinephrine reuptake inhibitors and is used to treat Fibromyalgia and Reflex Sympathetic Dystrophy Syndrome.
US matches:
- Milnacipran
- Milnacipran Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06AX17
CAS registry number (Chemical Abstracts Service)
0092623-85-3
Chemical Formula
C15-H22-N2-O
Molecular Weight
246
Therapeutic Category
Antidepressant: Selective serotonin and noradrenalin reuptake inhibitor (SSNRI)
Chemical Name
(±)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
Foreign Names
- Milnacipranum (Latin)
- Milnacipran (German)
- Milnacipran (French)
- Milnacipran (Spanish)
Generic Names
- Milnacipran (OS: DCF, USAN, BAN)
- F 2207 (IS: PierreFabre)
- Midalcipran (IS)
- Milnacipran Hydrochloride (OS: BANM, USAN)
Brand Names
- Dalcipran
Ferraz, Portugal - Ixel
Centapharm, Taiwan; Pierre Fabre, Tunisia - Dalcipran
PF, Luxembourg; Pierre Fabre, Czech Republic; Pierre Fabre Medicament, Slovakia; Roche, Argentina - Ixel
Janssen, Russian Federation; Janssen, Slovakia; PF, Luxembourg; Pierre Fabre, Argentina; Pierre Fabre, Austria; Pierre Fabre, Bulgaria; Pierre Fabre, Bahrain; Pierre Fabre, Czech Republic; Pierre Fabre, Estonia; Pierre Fabre, Georgia; Pierre Fabre, Israel; Pierre Fabre, Latvia; Pierre Fabre, Poland; Pierre Fabre, Portugal; Pierre Fabre, Romania; Pierre Fabre, Russian Federation; Pierre Fabre, Turkey; Pierre Fabre Médicament, Finland; Pierre Fabre Médicament, France; Roche, Brazil; Silesia, Chile - Savella
Forest, United States - Toledomin
Asahi Kasei, Japan
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment